BCL11A and Schnyder corneal dystrophy: By knocking out BCL11A, which negatively regulates y-globulin, patients with TDT and SCD show strong allelic editing levels after treatment in combination with myeloablation and increased fetal hemoglobin, improving their clinical picture.